Ironwood Pharmaceuticals, Inc.
IRWD
Positions held
Your positionsIRWD isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $639.48M | Enterprise value | $957.22M | Trailing P/E | 5.03 | Forward P/E | 2.58 |
| PEG | — | Price / book | -3.95 | Beta | 0.22 | Dividend yield | 0.00% |
| Revenue growth | 32.6% | Earnings growth | 125.7% | Gross margin | 77.2% | Operating margin | 70.2% |
| Profit margin | 33.4% | ROE | — | ROA | 47.0% | Debt / equity | — |
| Current ratio | 6.06 | Free cash flow | $121.83M | Analyst recommendation | none | Mean target | $6.10 |
| 52w high | $5.78 | 52w low | $1.41 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $113M | $107M | $47.7M | $122M | $85.2M | — |
| Op margin | 70.2% | 68.1% | 13.7% | 63.6% | 52.9% | — |
| Net income | $51.3M | $40.8M | -$2.3M | $40.1M | $23.6M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | $79.3M | $72.5M | $6.6M | $77.7M | $45.1M | — |
- Revenue +6% vs prior quarter ($113M vs $107M).
- Operating margin expanded to 70.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $296M | $351M | $443M | $411M | — |
| Op margin | 40.1% | 27.2% | 38.0% | 61.0% | — |
| Net income | $24.0M | $0.9M | -$1.0B | $175M | — |
| Gross margin | — | — | — | 100.0% | — |
| Gross profit | — | — | — | $411M | $414M |
| Operating income | $119M | $95.7M | $168M | $250M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
2026-09-30 · PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?
2026-09-14 · 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
2026-09-03 · Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference
2026-08-13 · Ironwood (IRWD) Q2 2026 Earnings Call Transcript
2026-08-07 · Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
2026-08-07 · Ironwood Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
2026-08-07 · Ironwood Pharmaceuticals (IRWD) Is Up 14.2% After Raising 2026 Revenue Guidance – Has The Bull Case Changed?
2026-08-06 · Ironwood Pharmaceuticals Inc (IRWD) (Q2 2026) Earnings Call Highlights: Strong LINZESS Growth ...
2026-08-06 · Ironwood Pharmaceuticals Q2 Earnings Call Highlights
2026-08-06 · Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates
2026-08-06 · Ironwood: Q2 Earnings Snapshot
Price (daily)
Full chart · RSI · MACD · patterns